These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The in vitro production of anti-DNA antibody by cultured peripheral blood or tonsillar lymphoid cells from normal donors and SLE patients. Cairns E; St Germain J; Bell DA J Immunol; 1985 Dec; 135(6):3839-44. PubMed ID: 3905965 [TBL] [Abstract][Full Text] [Related]
4. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics. Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730 [TBL] [Abstract][Full Text] [Related]
5. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052 [TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus]. Yang JH; Shen Q; Zhao DB; Cai Q; Han XH Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508 [TBL] [Abstract][Full Text] [Related]
7. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus. Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260 [TBL] [Abstract][Full Text] [Related]
8. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study. Dhir V; Singh AP; Aggarwal A; Naik S; Misra R Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102 [TBL] [Abstract][Full Text] [Related]
9. Lymphocyctes Tgammadelta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity. Robak E; Niewiadomska H; Robak T; Bartkowiak J; Błoński JZ; Woźniacka A; Pomorski L; Sysa-Jedrezejowska A Mediators Inflamm; 2001 Aug; 10(4):179-89. PubMed ID: 11577994 [TBL] [Abstract][Full Text] [Related]
10. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells. Devi BS; Van Noordin S; Krausz T; Davies KA J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931 [TBL] [Abstract][Full Text] [Related]
11. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship. Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365 [TBL] [Abstract][Full Text] [Related]
12. B cells lacking RP105, a novel B cell antigen, in systemic lupus erythematosus. Koarada S; Tada Y; Ushiyama O; Morito F; Suzuki N; Ohta A; Miyake K; Kimoto M; Nagasawa K Arthritis Rheum; 1999 Dec; 42(12):2593-600. PubMed ID: 10616005 [TBL] [Abstract][Full Text] [Related]
13. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033 [TBL] [Abstract][Full Text] [Related]
14. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares. Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999 [TBL] [Abstract][Full Text] [Related]
15. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus? Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929 [TBL] [Abstract][Full Text] [Related]
16. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus. Jacobi AM; Odendahl M; Reiter K; Bruns A; Burmester GR; Radbruch A; Valet G; Lipsky PE; Dörner T Arthritis Rheum; 2003 May; 48(5):1332-42. PubMed ID: 12746906 [TBL] [Abstract][Full Text] [Related]
17. Abnormal telomerase activity and telomere length in T and B cells from patients with systemic lupus erythematosus. Kurosaka D; Yasuda J; Yoshida K; Yoneda A; Yasuda C; Kingetsu I; Toyokawa Y; Yokoyama T; Saito S; Yamada A J Rheumatol; 2006 Jun; 33(6):1102-7. PubMed ID: 16755657 [TBL] [Abstract][Full Text] [Related]
18. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus. Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420 [TBL] [Abstract][Full Text] [Related]
19. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805 [TBL] [Abstract][Full Text] [Related]
20. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices. Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]